ANEB Anebulo Pharmaceuticals Inc Net earnings per share growth forecast for next year

Corporate emblem and logo of Anebulo Pharmaceuticals (ANEB)

Anebulo Pharmaceuticals (ANEB) faces geopolitical risks regarding patent registration and raw material procurement. The company develops cannabinoid overdose antidotes, funding its R&D through raised capital. Its environmental profile is limited to laboratory waste control. The value is fixed at 0.00, which clearly demonstrates the historical trend of the n+1 profit forecast.

ANEB: Anebulo Pharmaceuticals Inc Expected net earnings per share growth next year 07/04/2022 - 03/07/2026

Analytical breakdowns and data insights for company Anebulo Pharmaceuticals Inc (ANEB)

- share price and consensus valuation forecast:
Summary company analysis:ANEB, Anebulo Pharmaceuticals Inc
Brand item of Anebulo Pharmaceuticals, Inc.

The indicator measures analysts' average earnings growth expectations by aggregating forecasts for the coming year to assess the asset's fundamental attractiveness. The metric is sensitive to daily adjustments in market expectations, allowing for the rapid capture of industry reactions to quarterly reports. The projected earnings dynamics for Anebulo Pharmaceuticals (ANEB) over the next year reflect risks associated with patent disputes and geopolitical barriers in drug registration.

Competitors of Anebulo Pharmaceuticals

INDV (indivior.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year collegiumpharma.com (COLL)|Net earnings per share growth forecast for next year Cronos Group (CRON)|Canopy Growth Corp - Projected earnings per share growth rate for next year|Earnings growth forecast for next year HITI (High Tide Inc)|Aurora Cannabis (ACB) - Expected net earnings per share growth next year|achievelifesciences.com - Earnings growth forecast for next year|Expected net earnings per share growth next year Skye Bioscience|Canndoc (INCR) - Net earnings per share growth forecast for next year|NTRB - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year NSRX|Earnings growth forecast for next year igcinc.us|Earnings growth forecast for next year MIRA|floragrowth.ca (FLGC) - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year IMCC (IM Cannabis Corp)|Expected earnings per share trend next year ADIL|Artelo Biosciences Inc. - Earnings growth forecast for next year|ENSC: Net earnings per share growth forecast for next year|Titan Pharma (TTNP) - Net earnings per share growth forecast for next year|Greenlane Holdings - Expected earnings per share trend next year|INM (inmedpharma.com) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year AKAN (Akanda Corp.)|Net earnings per share growth forecast for next year Enveric Corp (ENVB)|Bright Green Corporation - Projected earnings per share growth rate for next year|Hempacco Co., Inc. - Expected earnings per share growth for next year